← back to search

Honggang Ke

Guangzhou University of Chinese Medicine · CN
Area of research
Pulmonary and Respiratory Medicine · Molecular Biology
Research interest
Research focused on Lung cancer and Cancer research, with related work in Oncology, microRNA, Adenocarcinoma. Notable publications include 'CXCL6 promotes non-small cell lung cancer cell survival and metastasis via down-regulation of miR-515-5p', 'Association of PTPRD/PTPRT Mutation With Better Clinical Outcomes in NSCLC Patients Treated With Immune Checkpoint Blockades', and 'Unique genomic profiles obtained from cerebrospinal fluid cell-free DNA of non-small cell lung cancer patients with leptomeningeal metastases'.
h-index
citations
460
works
20
NIH funding
primary concept
email

Recent publications

Marine natural product Methyl mycophenolate inhibits gastric cancer growth through regulating p53 and the downstream pathways
Cancer Cell International 2025cited by 0position: middledoi
Association of the SHOX2 and RASSF1A methylation levels with the pathological evolution of early-stage lung adenocarcinoma
BMC Cancer 2024cited by 15position: lastdoi
Tumor immune microenvironment analysis of non-small cell lung cancer development through multiplex immunofluorescence
Translational Lung Cancer Research 2024cited by 7position: middledoi
Immune microenvironment analysis and novel biomarkers of early-stage lung adenocarcinoma evolution
Frontiers in Oncology 2023cited by 6position: lastdoi
Association of PTPRD/PTPRT Mutation With Better Clinical Outcomes in NSCLC Patients Treated With Immune Checkpoint Blockades
Frontiers in Oncology 2021cited by 53position: middledoi
Procedure-specific prognostic impact of micropapillary subtype may guide resection strategy in small-sized lung adenocarcinomas: a multicenter study
Therapeutic Advances in Medical Oncology 2020cited by 34position: middledoi
<p>LncRNA RMRP Promotes Cell Proliferation and Invasion Through miR-613/NFAT5 Axis in Non-Small Cell Lung Cancer</p>
OncoTargets and Therapy 2020cited by 23position: middledoi
Prognostic impact of micropapillary component in patients with node‐negative subcentimeter lung adenocarcinoma: A Chinese cohort study
Thoracic Cancer 2020cited by 19position: middledoi
Lepidic component identifies a subgroup of lung adenocarcinoma with a distinctive prognosis: a multicenter propensity-matched analysis
Therapeutic Advances in Medical Oncology 2020cited by 18position: middledoi
Creation of a Prognostic Risk Prediction Model for Lung Adenocarcinoma Based on Gene Expression, Methylation, and Clinical Characteristics
Medical Science Monitor 2020cited by 12position: firstdoi
Impact of histological components on selecting limited lymphadenectomy for lung adenocarcinoma ≤ 2 cm
Lung Cancer 2020cited by 12position: middledoi
Distribution of NRG1 Gene Fusions in a Large Population of Chinese Patients with NSCLC
Journal of Thoracic Oncology 2019cited by 8position: firstdoi
Unique genomic profiles obtained from cerebrospinal fluid cell-free DNA of non-small cell lung cancer patients with leptomeningeal metastases
Cancer Biology & Therapy 2018cited by 46position: middledoi
Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy
Molecular and Cellular Biochemistry 2018cited by 34position: middledoi
Overexpression of RCN1 correlates with poor prognosis and progression in non–small cell lung cancer
Human Pathology 2018cited by 32position: lastdoi
The expression level and prognostic value of HIPK3 among non-small-cell lung cancer patients in China
OncoTargets and Therapy 2018cited by 15position: middledoi
CXCL6 promotes non-small cell lung cancer cell survival and metastasis via down-regulation of miR-515-5p
Biomedicine & Pharmacotherapy 2017cited by 69position: middledoi
Spondin2 is a new prognostic biomarker for lung adenocarcinoma
Oncotarget 2017cited by 20position: middledoi
Anterior fissureless uniport vs. posterior intra-fissure triple-port thoracoscopic right upper lobectomy: a propensity-matched study
Journal of Thoracic Disease 2017cited by 11position: firstdoi
MiR-129 regulates MMP9 to control metastasis of non-small cell lung cancer
Tumor Biology 2015cited by 26position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yifei Liu · Fujian Medical University4 papers (2017–2024)Hang Su · Guiyang Medical University4 papers (2020–2020)Huikang Xie · Tongji University4 papers (2020–2020) · 4 papers (2020–2020)Qian Li · Sun Yat-sen University3 papers (2017–2018)Ming Li · University of Electronic Science and Technology of China3 papers (2020–2020)Xiaoli Li · Shenzhen Institutes of Advanced Technology3 papers (2017–2018)Chang Chen · The First People's Hospital of Shunde3 papers (2020–2020)Jianguo Zhang · Henan Provincial People's Hospital3 papers (2017–2018)Jiaping Zhao · Nantong University3 papers (2023–2024)Tingting Bian · Nantong University3 papers (2017–2024)Hua Huang · The Ohio State University2 papers (2018–2018)Jian Liu · University of North Carolina at Chapel Hill2 papers (2017–2018)Jie Yao · The University of Texas Southwestern Medical Center2 papers (2020–2020)Chunyan Wu · The First Affiliated Hospital, Sun Yat-sen University2 papers (2020–2020)Yunlang She · Tongji University2 papers (2020–2020)Shengnan Zhao · Harbin Medical University2 papers (2020–2020)Chenyang Dai · Shandong University2 papers (2020–2020)Quan Zhu · Sichuan University2 papers (2020–2020)Jia Feng · Nantong University2 papers (2017–2018)